Iowa HSB151 mandates nonopioid drugs on the medical assistance preferred drug list and requires health carriers to develop a pain management access.

Iowa HSB151 ensures nonopioid drugs approved by the FDA for pain treatment are not disadvantaged on the medical assistance preferred drug list. Health carriers must develop a pain management access plan, providing coverage for at least two alternative prescription medication treatment options approved by the FDA for pain treatment, excluding schedule I, II, or III controlled substances. The plan must also cover a minimum of three alternative nonpharmacologic treatment modalities.

Iowa HSB151 mandates nonopioid drugs on the medical assistance preferred drug list and requires health carriers to develop a pain management access.

Iowa HSB151 ensures nonopioid drugs approved by the FDA for pain treatment are not disadvantaged on the medical assistance preferred drug list. Health carriers must develop a pain management access plan, providing coverage for at least two alternative prescription medication treatment options approved by the FDA for pain treatment, excluding schedule I, II, or III controlled substances. The plan must also cover a minimum of three alternative nonpharmacologic treatment modalities.